Unknown

Dataset Information

Cyclosporine A impairs the macrophage reverse cholesterol transport in mice by reducing sterol fecal excretion.


ABSTRACT: Despite the efficacy in reducing acute rejection events in organ transplanted subjects, long term therapy with cyclosporine A is associated with increased atherosclerotic cardiovascular morbidity. We studied whether this drug affects the antiatherogenic process of the reverse cholesterol transport from macrophages in vivo. Cyclosporine A 50 mg/kg/d was administered to C57BL/6 mice by subcutaneous injection for 14 days. Macrophage reverse cholesterol transport was assessed by following [(3)H]-cholesterol mobilization from pre-labeled intraperitoneally injected macrophages, expressing or not apolipoprotein E, to plasma, liver and feces. The pharmacological treatment significantly reduced the amount of radioactive sterols in the feces, independently on the expression of apolipoprotein E in th

SUBMITTER: Zanotti I 

PROVIDER: S-EPMC3739729 | biostudies-literature | 2013

REPOSITORIES: biostudies-literature